# Treatment for Ph-negative ALL for Adults up to 65 Years

> **NCT07443592** · NA · NOT_YET_RECRUITING · sponsor: **PETHEMA Foundation** · enrollment: 330 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Pediatric-type of chemotherapy (+blinatumomab for B-cell precursor ALL)
- **PROCEDURE:** Transplantation

## Key facts

- **NCT ID:** NCT07443592
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-06
- **Primary completion:** 2031-03-06
- **Final completion:** 2033-06-01
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07443592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07443592, "Treatment for Ph-negative ALL for Adults up to 65 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07443592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*